Prognosis of autoimmune pancreatitis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-05-22

AUTHORS

Terumi Kamisawa, Atsutake Okamoto

ABSTRACT

Autoimmune pancreatitis (AIP) is responsive to steroid therapy, but some AIP patients improve spontaneously, or only improve after biliary drainage. Pancreatic enlargement and irregular narrowing of the main pancreatic duct usually improves in almost all patients, but marked atrophy of the pancreas develops in some patients. Biliary stenosis improves to various degrees, and a biliary drainage tube can be withdrawn. Other extrapancreatic lesions, including swelling of the salivary or lacrimal glands, lymphadenopathy, and retroperitoneal fibrosis also improve with steroid therapy. Pancreatic endocrine and exocrine function is frequently impaired in AIP patients, and steroid therapy is occasionally effective for these dysfunction. Deterioration of pancreatic exocrine function is rarely detected after steroid therapy. In the literature, the recurrence rate of AIP was reported to be about 17% (range 6% to 26%). AIP patients who relapse during maintenance steroid therapy or after stopping steroid medication should be re-treated with a high-dose steroid. Although AIP is rarely associated with pancreatic stones, stones are formed in some relapsing AIP patients. The long-term prognosis for AIP is unknown. As the pancreatic exocrine and endocrine functions as well as the morphological findings are reversible after steroid therapy, the prognosis for AIP seems better than that of chronic pancreatitis, which is usually followed by exocrine and endocrine pancreatic insufficiency with disease progression. Although carcinogenesis of AIP is unknown, some AIP patients developed a malignancy during follow-up. Since AIP occurs predominantly in the elderly, clinicians should pay attention to any complicating diseases in follow-up of AIP patients. Further studies are necessary to clarify the pathogenesis as well as the long-term prognosis of AIP. More... »

PAGES

59-62

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00535-007-2052-x

DOI

http://dx.doi.org/10.1007/s00535-007-2052-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000352723

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17520225


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autoimmune Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glucocorticoids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatitis, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Tokyo Metropolitan Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Department of Medicine, Tokyo Metropolitan Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kamisawa", 
        "givenName": "Terumi", 
        "id": "sg:person.01246337055.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246337055.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Department of Surgery, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okamoto", 
        "givenName": "Atsutake", 
        "id": "sg:person.016443750202.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016443750202.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00428-004-1140-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034513586", 
          "https://doi.org/10.1007/s00428-004-1140-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-006-1862-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053147905", 
          "https://doi.org/10.1007/s00535-006-1862-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1024743218697", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040691381", 
          "https://doi.org/10.1023/a:1024743218697"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2004.04162.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014747019", 
          "https://doi.org/10.1111/j.1572-0241.2004.04162.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2003.08775.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029598891", 
          "https://doi.org/10.1111/j.1572-0241.2003.08775.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2004.30336.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049346790", 
          "https://doi.org/10.1111/j.1572-0241.2004.30336.x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-05-22", 
    "datePublishedReg": "2007-05-22", 
    "description": "Autoimmune pancreatitis (AIP) is responsive to steroid therapy, but some AIP patients improve spontaneously, or only improve after biliary drainage. Pancreatic enlargement and irregular narrowing of the main pancreatic duct usually improves in almost all patients, but marked atrophy of the pancreas develops in some patients. Biliary stenosis improves to various degrees, and a biliary drainage tube can be withdrawn. Other extrapancreatic lesions, including swelling of the salivary or lacrimal glands, lymphadenopathy, and retroperitoneal fibrosis also improve with steroid therapy. Pancreatic endocrine and exocrine function is frequently impaired in AIP patients, and steroid therapy is occasionally effective for these dysfunction. Deterioration of pancreatic exocrine function is rarely detected after steroid therapy. In the literature, the recurrence rate of AIP was reported to be about 17% (range 6% to 26%). AIP patients who relapse during maintenance steroid therapy or after stopping steroid medication should be re-treated with a high-dose steroid. Although AIP is rarely associated with pancreatic stones, stones are formed in some relapsing AIP patients. The long-term prognosis for AIP is unknown. As the pancreatic exocrine and endocrine functions as well as the morphological findings are reversible after steroid therapy, the prognosis for AIP seems better than that of chronic pancreatitis, which is usually followed by exocrine and endocrine pancreatic insufficiency with disease progression. Although carcinogenesis of AIP is unknown, some AIP patients developed a malignancy during follow-up. Since AIP occurs predominantly in the elderly, clinicians should pay attention to any complicating diseases in follow-up of AIP patients. Further studies are necessary to clarify the pathogenesis as well as the long-term prognosis of AIP.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00535-007-2052-x", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1009747", 
        "issn": [
          "0944-1174", 
          "1435-5922"
        ], 
        "name": "Journal of Gastroenterology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 18", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "keywords": [
      "steroid therapy", 
      "autoimmune pancreatitis", 
      "long-term prognosis", 
      "AIP patients", 
      "exocrine function", 
      "maintenance steroid therapy", 
      "high-dose steroids", 
      "endocrine pancreatic insufficiency", 
      "biliary drainage tube", 
      "main pancreatic duct", 
      "pancreatic exocrine function", 
      "irregular narrowing", 
      "biliary stenosis", 
      "steroid medication", 
      "biliary drainage", 
      "extrapancreatic lesions", 
      "complicating diseases", 
      "chronic pancreatitis", 
      "recurrence rate", 
      "drainage tube", 
      "pancreatic enlargement", 
      "pancreatic duct", 
      "disease progression", 
      "pancreatic insufficiency", 
      "pancreatic exocrine", 
      "pancreatic stones", 
      "endocrine function", 
      "patients", 
      "pancreatic endocrine", 
      "lacrimal gland", 
      "therapy", 
      "prognosis", 
      "morphological findings", 
      "pancreatitis", 
      "Further studies", 
      "exocrine", 
      "lymphadenopathy", 
      "medications", 
      "stenosis", 
      "atrophy", 
      "malignancy", 
      "fibrosis", 
      "dysfunction", 
      "pathogenesis", 
      "insufficiency", 
      "lesions", 
      "pancreas", 
      "steroids", 
      "clinicians", 
      "disease", 
      "progression", 
      "carcinogenesis", 
      "endocrine", 
      "gland", 
      "stones", 
      "enlargement", 
      "duct", 
      "narrowing", 
      "drainage", 
      "function", 
      "findings", 
      "deterioration", 
      "study", 
      "rate", 
      "literature", 
      "degree", 
      "tube", 
      "attention"
    ], 
    "name": "Prognosis of autoimmune pancreatitis", 
    "pagination": "59-62", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000352723"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00535-007-2052-x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17520225"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00535-007-2052-x", 
      "https://app.dimensions.ai/details/publication/pub.1000352723"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_449.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00535-007-2052-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00535-007-2052-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00535-007-2052-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00535-007-2052-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00535-007-2052-x'


 

This table displays all metadata directly associated to this object as RDF triples.

195 TRIPLES      22 PREDICATES      108 URIs      94 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00535-007-2052-x schema:about N28188093ded64d73b272051b5d0f40cd
2 N2ec47ec905a9405eb4c0ca08dd3c00fb
3 N39cb59fe4cbb48c49a7d44c24c67c785
4 N5f6eb12d2411427a9a0ffb773a94cc57
5 N985b806c0b17474fbff14a698a136da4
6 Nbf602fd776424317aedf7ead82d1d8eb
7 Ncb6df543357143a5926f6fa2581bb1be
8 Nf2efdbc604334aba86adfcbfc614687f
9 anzsrc-for:11
10 anzsrc-for:1103
11 schema:author N26283eae014d42b4a382ddfc7736c350
12 schema:citation sg:pub.10.1007/s00428-004-1140-z
13 sg:pub.10.1007/s00535-006-1862-6
14 sg:pub.10.1023/a:1024743218697
15 sg:pub.10.1111/j.1572-0241.2003.08775.x
16 sg:pub.10.1111/j.1572-0241.2004.04162.x
17 sg:pub.10.1111/j.1572-0241.2004.30336.x
18 schema:datePublished 2007-05-22
19 schema:datePublishedReg 2007-05-22
20 schema:description Autoimmune pancreatitis (AIP) is responsive to steroid therapy, but some AIP patients improve spontaneously, or only improve after biliary drainage. Pancreatic enlargement and irregular narrowing of the main pancreatic duct usually improves in almost all patients, but marked atrophy of the pancreas develops in some patients. Biliary stenosis improves to various degrees, and a biliary drainage tube can be withdrawn. Other extrapancreatic lesions, including swelling of the salivary or lacrimal glands, lymphadenopathy, and retroperitoneal fibrosis also improve with steroid therapy. Pancreatic endocrine and exocrine function is frequently impaired in AIP patients, and steroid therapy is occasionally effective for these dysfunction. Deterioration of pancreatic exocrine function is rarely detected after steroid therapy. In the literature, the recurrence rate of AIP was reported to be about 17% (range 6% to 26%). AIP patients who relapse during maintenance steroid therapy or after stopping steroid medication should be re-treated with a high-dose steroid. Although AIP is rarely associated with pancreatic stones, stones are formed in some relapsing AIP patients. The long-term prognosis for AIP is unknown. As the pancreatic exocrine and endocrine functions as well as the morphological findings are reversible after steroid therapy, the prognosis for AIP seems better than that of chronic pancreatitis, which is usually followed by exocrine and endocrine pancreatic insufficiency with disease progression. Although carcinogenesis of AIP is unknown, some AIP patients developed a malignancy during follow-up. Since AIP occurs predominantly in the elderly, clinicians should pay attention to any complicating diseases in follow-up of AIP patients. Further studies are necessary to clarify the pathogenesis as well as the long-term prognosis of AIP.
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf N1579d707c9524b0f950ffd5249baeeb3
25 N22ea248355e1417ebfd58a064a29a7ba
26 sg:journal.1009747
27 schema:keywords AIP patients
28 Further studies
29 atrophy
30 attention
31 autoimmune pancreatitis
32 biliary drainage
33 biliary drainage tube
34 biliary stenosis
35 carcinogenesis
36 chronic pancreatitis
37 clinicians
38 complicating diseases
39 degree
40 deterioration
41 disease
42 disease progression
43 drainage
44 drainage tube
45 duct
46 dysfunction
47 endocrine
48 endocrine function
49 endocrine pancreatic insufficiency
50 enlargement
51 exocrine
52 exocrine function
53 extrapancreatic lesions
54 fibrosis
55 findings
56 function
57 gland
58 high-dose steroids
59 insufficiency
60 irregular narrowing
61 lacrimal gland
62 lesions
63 literature
64 long-term prognosis
65 lymphadenopathy
66 main pancreatic duct
67 maintenance steroid therapy
68 malignancy
69 medications
70 morphological findings
71 narrowing
72 pancreas
73 pancreatic duct
74 pancreatic endocrine
75 pancreatic enlargement
76 pancreatic exocrine
77 pancreatic exocrine function
78 pancreatic insufficiency
79 pancreatic stones
80 pancreatitis
81 pathogenesis
82 patients
83 prognosis
84 progression
85 rate
86 recurrence rate
87 stenosis
88 steroid medication
89 steroid therapy
90 steroids
91 stones
92 study
93 therapy
94 tube
95 schema:name Prognosis of autoimmune pancreatitis
96 schema:pagination 59-62
97 schema:productId N221317d718dd44c1ac497ddaf9076345
98 N4b1d583364574d9a9b8cf9008f58a42f
99 Nb4e6847037cc45a68696dfe3b301e720
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000352723
101 https://doi.org/10.1007/s00535-007-2052-x
102 schema:sdDatePublished 2022-05-20T07:24
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher N7d69291b86ca42bda1ab9d0dc33e23e6
105 schema:url https://doi.org/10.1007/s00535-007-2052-x
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N1579d707c9524b0f950ffd5249baeeb3 schema:issueNumber Suppl 18
110 rdf:type schema:PublicationIssue
111 N221317d718dd44c1ac497ddaf9076345 schema:name doi
112 schema:value 10.1007/s00535-007-2052-x
113 rdf:type schema:PropertyValue
114 N22ea248355e1417ebfd58a064a29a7ba schema:volumeNumber 42
115 rdf:type schema:PublicationVolume
116 N26283eae014d42b4a382ddfc7736c350 rdf:first sg:person.01246337055.41
117 rdf:rest Nd8b1bd4cdbde4bc285a7ee6045a99413
118 N28188093ded64d73b272051b5d0f40cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Pancreatitis, Chronic
120 rdf:type schema:DefinedTerm
121 N2ec47ec905a9405eb4c0ca08dd3c00fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Aged, 80 and over
123 rdf:type schema:DefinedTerm
124 N39cb59fe4cbb48c49a7d44c24c67c785 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Recurrence
126 rdf:type schema:DefinedTerm
127 N4b1d583364574d9a9b8cf9008f58a42f schema:name dimensions_id
128 schema:value pub.1000352723
129 rdf:type schema:PropertyValue
130 N5f6eb12d2411427a9a0ffb773a94cc57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Aged
132 rdf:type schema:DefinedTerm
133 N7d69291b86ca42bda1ab9d0dc33e23e6 schema:name Springer Nature - SN SciGraph project
134 rdf:type schema:Organization
135 N985b806c0b17474fbff14a698a136da4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Autoimmune Diseases
137 rdf:type schema:DefinedTerm
138 Nb4e6847037cc45a68696dfe3b301e720 schema:name pubmed_id
139 schema:value 17520225
140 rdf:type schema:PropertyValue
141 Nbf602fd776424317aedf7ead82d1d8eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Prognosis
143 rdf:type schema:DefinedTerm
144 Ncb6df543357143a5926f6fa2581bb1be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Glucocorticoids
146 rdf:type schema:DefinedTerm
147 Nd8b1bd4cdbde4bc285a7ee6045a99413 rdf:first sg:person.016443750202.14
148 rdf:rest rdf:nil
149 Nf2efdbc604334aba86adfcbfc614687f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Humans
151 rdf:type schema:DefinedTerm
152 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
153 schema:name Medical and Health Sciences
154 rdf:type schema:DefinedTerm
155 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
156 schema:name Clinical Sciences
157 rdf:type schema:DefinedTerm
158 sg:journal.1009747 schema:issn 0944-1174
159 1435-5922
160 schema:name Journal of Gastroenterology
161 schema:publisher Springer Nature
162 rdf:type schema:Periodical
163 sg:person.01246337055.41 schema:affiliation grid-institutes:grid.415479.a
164 schema:familyName Kamisawa
165 schema:givenName Terumi
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246337055.41
167 rdf:type schema:Person
168 sg:person.016443750202.14 schema:affiliation grid-institutes:grid.415479.a
169 schema:familyName Okamoto
170 schema:givenName Atsutake
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016443750202.14
172 rdf:type schema:Person
173 sg:pub.10.1007/s00428-004-1140-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1034513586
174 https://doi.org/10.1007/s00428-004-1140-z
175 rdf:type schema:CreativeWork
176 sg:pub.10.1007/s00535-006-1862-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053147905
177 https://doi.org/10.1007/s00535-006-1862-6
178 rdf:type schema:CreativeWork
179 sg:pub.10.1023/a:1024743218697 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040691381
180 https://doi.org/10.1023/a:1024743218697
181 rdf:type schema:CreativeWork
182 sg:pub.10.1111/j.1572-0241.2003.08775.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1029598891
183 https://doi.org/10.1111/j.1572-0241.2003.08775.x
184 rdf:type schema:CreativeWork
185 sg:pub.10.1111/j.1572-0241.2004.04162.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1014747019
186 https://doi.org/10.1111/j.1572-0241.2004.04162.x
187 rdf:type schema:CreativeWork
188 sg:pub.10.1111/j.1572-0241.2004.30336.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049346790
189 https://doi.org/10.1111/j.1572-0241.2004.30336.x
190 rdf:type schema:CreativeWork
191 grid-institutes:grid.415479.a schema:alternateName Department of Medicine, Tokyo Metropolitan Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan
192 Department of Surgery, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
193 schema:name Department of Medicine, Tokyo Metropolitan Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan
194 Department of Surgery, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
195 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...